Skip to main content
SpringerLink
Log in
Book cover

Andrology pp 399–418Cite as

Male Contribution to Contraception

  • Chapter

Abstract

Making contraceptive methods available to men is one of the tasks of andrology. Such methods are necessary both to maintain stable populations in industrial nations, as well as to diminish population growth in developing countries (see Chap. 17).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akhtar FB, Marshall GR, Wickings EJ, Nieschlag E (1983a) Reversible induction of azoospermia in rhesus monkeys by constant infusion of a GnRH agonist using osmotic minipumps. J Clin Endocrinol Metab 56:534

    Article  PubMed  CAS  Google Scholar 

  • Akhtar FB, Marshall GR, Nieschlag E (1983b) Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male monkeys. Int J Androl 6:461

    Article  PubMed  CAS  Google Scholar 

  • Alan Guttmacher Institute (1999) Sharing responsibility: women, society and abortion worldwide. New York

    Google Scholar 

  • Alderman PM (1991) Complications in a series of 1224 vasectomies. J Fam Pract 33:579–584

    PubMed  CAS  Google Scholar 

  • Anawalt BD, Bebb RA, Bremner WJ, Matsumoto AM (1999) A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations. J Androl 20:407–414

    PubMed  CAS  Google Scholar 

  • Anderson RA, Baird DT (1997) Progress towards a male pill. IPPF Med Bull 31:3–4

    Google Scholar 

  • April K, Köster R, Schreiner W (1993) Wie effektiv schützen Kondome vor einer HIV-Übertragung? Med Klinik 88:304–311

    CAS  Google Scholar 

  • Bagatell CJ, Matsumoto AM, Christensen RB, Rivier JE, Bremner WJ (1993) Comparison of a gonadotropin-releasing hormone antagonist plus testosterone (T) versus T alone as a potential male contraceptive regimen. J Clin Endocrinol Metab 77:427

    Article  PubMed  CAS  Google Scholar 

  • Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM (1996) Combined administration of levornorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab 81:757–762

    Article  PubMed  CAS  Google Scholar 

  • Behre HM, Nashan D, Hubert W, Nieschlag E (1992) Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. J Clin Endocrinol Metab 74:84

    Article  PubMed  CAS  Google Scholar 

  • Behre HM, Böckers A, Schlingheider A, Nieschlag E (1994) Sustained suppression of serum LH, FSH and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men. Clin Endocrinol 40:241

    Article  CAS  Google Scholar 

  • Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E (1995) Potential of testosterone buciclate for male contraception: endocrine differences between responders and non-responders. J Clin Endocrinol Metab 80:2394–2403

    Article  PubMed  CAS  Google Scholar 

  • Belker AM, Thomas AJ, Fuchs EF, Konnak JW, Sharlip ID (1991) Result of 1,469 microsurgical vasectomy reversals by the vasovasostomy study group. J Urol 145:505–511

    PubMed  CAS  Google Scholar 

  • Bonnar J, Flynn A, Freundl G, Kirkman R, Royston R, Snowden R (1999) Personal hormone monitoring for contraception. Br J Fam Plann 24:128–134

    PubMed  CAS  Google Scholar 

  • Büchter D, von Eckardstein S, von Eckardstein A, Kamischke A, Simoni M, Behre HM, Nieschlag E (1999) Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab 84:1244–1249

    Article  PubMed  Google Scholar 

  • Cooper TG, Yeung CH (1999) Recent biochemical approaches to post-testicular, epididymal contraception. Hum Reprod Update 5:141–152

    Article  PubMed  CAS  Google Scholar 

  • Cos LR, Valvo JR, Davis RS, Cockett ATK (1983) Vasovasostomy: current state of the art. Urology 22:567–575

    Article  PubMed  CAS  Google Scholar 

  • Deindl F (1990) Die Refertilisationssituation in der Bundesrepublik Deutschland, der Republik Österreich und der Schweiz — eine Dreiländerumfrage. Inaugural-Dissertation, Ruhr-Universität Bochum

    Google Scholar 

  • Delanoe D, Fougeyrollas B, Meyer L, Thonneau P (1984) Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception. Lancet 1:276

    Article  PubMed  CAS  Google Scholar 

  • Derrick FC, Yarbbrough W, Agostino JD (1973) Vasovasostomy: results of questionnaire of members of the American Urological Association. J Urol 110:556–557

    PubMed  Google Scholar 

  • Djerassi C, Leibo SP (1994) A new look at male contraception. Nature 370:11–12

    Article  PubMed  CAS  Google Scholar 

  • De Vincenzi I for the European Study Group on Heterosexual Transmission of HIV (1994) A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 331:341–346

    Article  Google Scholar 

  • Drake MJ, Mills IW, Cranston D (1999) On the chequered history of vasectomy. Br J Urol Int 84:475–481

    Article  CAS  Google Scholar 

  • Engelmann UH, Schramek P, Tomamichel G, Deindl F, Senge TH (1990) Vasectomy reversal in central Europe: results of a questionnaire of urologists in Austria, Germany and Switzerland. J Urol 143:64–67

    PubMed  CAS  Google Scholar 

  • Farley TMM; Meirik O, Mehta S, Waites GMH (1993) The safety of vasectomy: recent concerns. Bull WHO 71:413–419

    PubMed  CAS  Google Scholar 

  • Farnsworth NR, Waller DP (1982) Current status of plant products reported to inhibit sperm. Res Front Fertil Regul 2:1–16

    PubMed  CAS  Google Scholar 

  • Feber KM, Ruiz HE (1999) Vasovasostomy: macroscopic approach and retrospective review. Techniques Urol 5:8–11

    CAS  Google Scholar 

  • Forste R, Tanfer K, Tedrow L (1995) Sterilization among currently married men in the United States, 1991. Fam Plann Perspect 27:100–107, 122

    Article  PubMed  CAS  Google Scholar 

  • Frezieres RG, Walsh TL, Nelson AL, Clark VA, Coulson AH (1999) Evaluation of the efficacy of a polyurethane condom: results from a randomized, controlled clinical trial. Fam Plann Perspect 31:81–87

    Article  PubMed  CAS  Google Scholar 

  • Giovanucci E, Tosteson TD, Speizer FE, Vessey MP, Colditz GA (1992) A long-term study of mortality in men who have undergone vasectomy. N Engl J Med 326:1392–1398

    Article  Google Scholar 

  • Giovanucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1993) A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 269:873–877

    Article  Google Scholar 

  • Giwercman A, Skakkebaek NE (1986) The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. A review. Int J Androl 9:38

    Article  PubMed  CAS  Google Scholar 

  • Goebel P, Ortmann K, Blattner TH (1987) Vasektomie und Beziehungssituation — eine empirische Untersuchung an 156 Männern (Paaren). Zschr Psychosom Med 33:119–138

    CAS  Google Scholar 

  • Goldstein M, Shihua PhL, Matthews GJ (1998) Microsurgical Vasovasostomy: The microdot technique of precision suture placement. J Urol 159:188–190

    Article  PubMed  CAS  Google Scholar 

  • Handelsman DJ, Conway AJ, Boylan LM (1992) Suppression of human spermatogenesis by testosterone implants. J Clin Endocrinol Metab 175:1326

    Article  Google Scholar 

  • Heidenreich A, Bonfig R, Wilbert DM, Strohmaier WL, Engelmann UH (1994) Risk factors for antisperm antibodies in infertile men. Am J Reprod Immunol 31:69–76

    Article  PubMed  CAS  Google Scholar 

  • Hiersche HD, Hiersche F (1995) Die Sterilisation geistig Behinderter. Gynäkologe 28:452–458

    PubMed  CAS  Google Scholar 

  • Isnardi L (1896) Die Behandlung der senilen Dysurie mit Durchschneidung und doppelseitiger Ligatur der vasa deferentia. Ther Wochenschr 111:25–36

    Google Scholar 

  • Jequier AM, Pryor JP (1998) Is vasectomy of long term benefits? Hum Reprod 13:1757–1760

    Article  PubMed  CAS  Google Scholar 

  • John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, West DW, Hankin J, Dreon DM, Teh CZ (1995) Vasectomy and prostate cancer: results from a multiethnic casecontrol study. J Natl Cancer Inst 87:662–669

    Article  PubMed  CAS  Google Scholar 

  • Kamischke A, Nieschlag E (2000) Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo controlled clinical trial for male contraception. Clin Endocrinol 53:43–52

    Article  CAS  Google Scholar 

  • Knuth UA, Mühlenstedt D (1991) Kinderwunschdauer, kontrazeptives Verhalten und Rate vorausgegangener Infertilitätsbehandlung. Geburtsh Frauenheilkd 51:1–7

    Article  Google Scholar 

  • Knuth UA, Behre HM, Beikien L, Bents H, Nieschlag E (1985) Clinical trial of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) for male fertility regulation. Fertil Steril 44:814

    PubMed  CAS  Google Scholar 

  • Knuth UA, Yeung CH, Nieschlag E (1989) Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception. Fertil Steril 51:1011

    PubMed  CAS  Google Scholar 

  • Kohli KL (1973) Motivational factors and socioeconomic characteristics of vasectomized males. J Biosoc Sci 5:169–177

    Article  PubMed  CAS  Google Scholar 

  • Leonard JM, Paulsen CA (1978) Contraceptive development studies for males: oral and parenteral steroid hormone administation. In: Pantanelli DJ (ed) Hormonal control of male fertility. Department of Health, Education and Welfare. National Institutes of Health, Bethesda, pp 223

    Google Scholar 

  • Lesko SM, Louik C, Vezina R, Rosenberg L, Shapiro S (1999) Vasectomy and prostate cancer. J Urol 161:1848–1853

    Article  PubMed  CAS  Google Scholar 

  • Liu X, Li S (1993) Vasal sterilization in China. Contraception 48:255–265

    Article  PubMed  CAS  Google Scholar 

  • Martin CW, Anderson RA, Cheng L, Ho PC, van der Spuy Z, Smith KB, Glasier AF, Everington D, Baird DT (2000) Potential impact of hormonal male contraception: cross cultural implications for development of novel preparations. Hum Reprod 15:637–645

    Article  PubMed  CAS  Google Scholar 

  • Meriggiola MC, Paulsen CA, Bremner WJ, Flamigni C (1996) A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. J Clin Endocrinol Metab 81:3018–3023

    Article  PubMed  CAS  Google Scholar 

  • Meriggiola MC, Bremner WJ, Constantino A, Pavani A, Capelli M, Flamigni C (1997) An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men. Fertil Steril 68:844–850

    Article  PubMed  CAS  Google Scholar 

  • Mieusset R, Bujan L (1994) The potential of mild testicular heating as a safe, effective and reversible contraceptive method for men. Int J Androl 17:186–191

    Article  PubMed  CAS  Google Scholar 

  • Miltsch B, Senn E (1999) Vasektomie: Präoperative Bedenken und postoperative Akzeptanz. Aktuel Urol 30:237–241

    Article  Google Scholar 

  • Moltz L, Römmler A, Post A, Schwartz U, Hammerstein J (1980) Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men. Contraception 21:393

    Article  PubMed  CAS  Google Scholar 

  • National Institutes of Health (1993) Does vasectomy cause prostate cancer? JAMA 269:2620

    Article  Google Scholar 

  • Nieschlag E (1986) Reasons for abandoning immunization against FSH as an approach to male fertility regulation. In: Zatuchni GI, Goldsmith A, Spieler JM, Sciarra JJ (eds) Male contraception: advances and future prospects. Harper and Row, Philadelphia, pp 395–400

    Google Scholar 

  • Nieschlag E (1987) Vasektomie — pro und contra. Dtsch Med Wochenschr 112:1107–1109

    Article  PubMed  CAS  Google Scholar 

  • Nieschlag E, Behre HM, Weinbauer GF (1992) Hormonal male contraception: A real chance? In: Nieschlag E, Habenicht UF (eds) Spermatogenesis — fertilitzation — contraception. Molecular, cellular and endocrine events in male reproduction. Springer, Berlin Heidelberg New York, pp 477–501

    Chapter  Google Scholar 

  • Nieschlag E, Behre HM (1996) Hormonal male contraception: Suppression of spermatogenesis with GnRH antagonists and testosterone. In: Filicori M (ed) Treatment with GnRH analogs: controversies and perspectives. Parthenon, London, pp 243–248

    Google Scholar 

  • Nieschlag E, Hoogen H, Bölk M, Schuster H, Wickings EJ (1978) Clinical trial with testosterone undecanoate for male fertility control. Contraception 18: 607

    Article  PubMed  CAS  Google Scholar 

  • Nirapathpongporn A, Huber DH, Krieger JN (1990) No-scalpel vasectomy at the King’s birthday vasectomy festival. Lancet 335:894–895

    Article  PubMed  CAS  Google Scholar 

  • Ochsner AJ (1899) Surgical treatment of habitual criminals. JAMA 33:867–868

    Article  Google Scholar 

  • O’Connor VJ (1948) Anastomosis of the vas deferens after purposeful division for sterility. J Urol 59:229–233

    Google Scholar 

  • Pavlou SN, Herodotou D, Curtain M, Minaretzis D (1994) Complete suppression of spermatogenesis by co-administration of a GnRH antagonist plus a physiologic dose of testosterone. 76th Meeting Endocrine Society, Abstract 1324

    Google Scholar 

  • Prasad MR, Diczfalusy NE (1982) Gossypol. Int J Androl [Suppl] 28:53

    Article  Google Scholar 

  • Randall PE, Marcuson RW (1985) Absence from work following vasectomy. J Soc Occup Med 35:77–78

    Article  PubMed  CAS  Google Scholar 

  • Reissmann T, Engel J, Kutscher B, Bernd M, Hilgard P, Peukert M, Szelenyi I, Reichert S, Gonzales-Barcena D, Nieschlag E, Comary-Schally AM, Schally AV (1994) Cetrorelix. Drugs Future 19:228–237

    Google Scholar 

  • Reynolds RD (1994) Vas deferens occlusion during no-scalpel vasectomy. J Fam Pract 39:577–582

    PubMed  CAS  Google Scholar 

  • Rizvi SAH, Naqvi SAA, Hussain Z (1995) Ethical issues in male sterilization in developing countries. Br J Urol 76:103–105

    Article  PubMed  Google Scholar 

  • Rosenberg MJ, Waugh MS (1997) Latex condom breakage and slippage in a controlled clinical trial. Contraception 56:17–21

    Article  PubMed  CAS  Google Scholar 

  • Ross JA, Huber DH (1983) Acceptance and prevalence of vasectomy in developing countries. Stud Fam Plan 14:67–73

    Article  CAS  Google Scholar 

  • Roth S, Hertle L (1994) Verursacht die Sterilisations-Vasekto-mie ein Prostatakarzinom? Dt Ärztebl 91:409–410

    Google Scholar 

  • Rothman I, Berger RE, Cummings P, Jessen J, Muller ChH, Chapman W (1997) Randomized clinical trial of an absorbable stent for vasectomy reversal. J Urol 157:1697–1700

    Article  PubMed  CAS  Google Scholar 

  • Russell-Brown P, Piedrahita C, Foldesy R, Steiner M, Townsend J (1992) Comparison of condom breakage during human use with performance in laboratory testing. Contraception 45:429–437

    Article  PubMed  CAS  Google Scholar 

  • Sanches FA, Brache V, Leon P, Faundes A (1979) Inhibition of spermatogenesis with monthly injections of medroxyprogesterone acetate and low dose testosterone enanthate. Int J Androl 2:136

    Article  Google Scholar 

  • Schearer SB (1978) The use of progestins and androgens as a male contraceptive. Int J Androl [Suppl] 2:680

    Article  Google Scholar 

  • Schirren C (1983) Erfahrungen mit der Vasektomie. Urologe A 22:29–34

    PubMed  CAS  Google Scholar 

  • Schürmeyer T, Knuth UA, Freischem CW, Sandow J, Akhtar FB, Nieschlag E (1984) Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion. J Clin Endocrinol Metab 59:19

    Article  PubMed  Google Scholar 

  • Segal SJ (1985) Gossypol: a potential contraceptive for men. Plenum, New York

    Google Scholar 

  • Sharp HC (1902) The severing of the vasa deferentia and its relation to the neuropsychopathic constitution. NY Med J 75:411–414

    Google Scholar 

  • Silber SJ (1977) Perfect anatomical reconstruction of vas deferens with a new microscopic surgical technique. Fertil Steril 28:72–77

    PubMed  CAS  Google Scholar 

  • Smith GL, Taylor GP, Smith KF (1985) Comparative risks and costs of male and female sterilization. Am J Pub Health 75:370–374

    Article  CAS  Google Scholar 

  • Soufir J-C, Jouannet P, Marson J, Soumah A (1983) Reversible inhibition of sperm production and gonadotropin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Acta Endocrinol 102:625

    PubMed  CAS  Google Scholar 

  • Steiner M, Foldesy R, Cole D, Carter E (1992) Study to determine the correlation between condom breakage in human use and laboratory test results. Contraception 46:279–288

    Article  PubMed  CAS  Google Scholar 

  • Trussell J, Hatcher RA, Cates W, Stewart FH, Kost K (1990) Contraceptive failure in the United States: an update. Stud Fam Plan 21:51–54

    Article  CAS  Google Scholar 

  • Vaughn R (1979) Behavioral response to vasectomy. Arch Gen Psychiatry 36:815–821

    Article  PubMed  CAS  Google Scholar 

  • Waites GMH (1993) Male fertility regulation: the challenges for the year 2000. Br Med Bull 49:210

    PubMed  CAS  Google Scholar 

  • Waites GMH, Wang C, Griffin PD (1998) Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug. Int J Androl 21:8–12

    Article  PubMed  CAS  Google Scholar 

  • Wang C, Yeung KK (1980) Use of low-dosage oral cyproterone acetate as a male contraceptive. Contraception 21:245

    Article  PubMed  CAS  Google Scholar 

  • Wang C, McDonald V, Leung A, Superlano L, Berman N, Hull L, Swerdloff RS (1997) Effect of increased scrotal temperature on sperm production in normal men. Fertil Steril 68:334–339

    Article  PubMed  CAS  Google Scholar 

  • Weidner W, Weißbach L (1992) Freiwillige Vasektomie in der Familienplanung — Gedanken zur Nutzen-Risiko-Analyse. Aktuel Urol 23:328–331

    Article  Google Scholar 

  • Weinbauer GF, Göckeler E, Nieschlag E (1988) Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone (GnRH) antagonist-treated nun-human primate (Macaca fascicularis). J Clin Endocrinol Metab 67:284

    Article  PubMed  CAS  Google Scholar 

  • Weller SC (1993) A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 36:1635–1644

    Article  PubMed  CAS  Google Scholar 

  • WHO (1972–1998) Special programme of research, development and research training in human reproduction. Annual and biannual reports. WHO, Genf

    Google Scholar 

  • WHO Task Force on Methods for the Regulation of Male Fertility (1990) Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336:955–959

    Article  Google Scholar 

  • WHO Task Force on Methods for the Regulation of Male Fertility (1993) Comparison of two androgens plus depot-me-droxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertil Steril 60:1062

    Google Scholar 

  • WHO Task Force on Methods for the Regulation of Male Fertility (1995) Rate of testosterone-induced suppression to severe oligozoospermia or azoospermia in two multinational clinical studies. Int J Androl 18:157–165

    Article  Google Scholar 

  • WHO Task Force on Methods for the Regulation of Male Fertility (1996) Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 65:821–829

    Google Scholar 

  • WHO/HRP (1997) Preclinical and clinical requirements for approval to market non-latex condoms. WHO, Genf

    Google Scholar 

  • Wicklund R, Alexander NJ (1979) Vasovasostomy: evaluation of success. Urology 13:532–534

    Article  PubMed  CAS  Google Scholar 

  • Wolfers D, Wolfers H (1974) Vasectomy and vasectomania. Mayflower Books, London

    Google Scholar 

  • Wright N, Johnson B, Wiggins P, Vessey M (1977) The use of sterilisation as a method of birth control among participants in the Oxford/Family Planning Association Contraceptive Study. Fertil Contracept 1:41–44

    Google Scholar 

  • Wu FC, Balasubramanian R, Mulders TM, Coelingh-Benningk HJ (1999) Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. J Clin Endocrinol Metab 84:112–122

    Article  PubMed  CAS  Google Scholar 

  • Yu Z-H, Chan HC (1998) Gossypol as a male antifertility agent — why studies should have been continued. Int J Androl 21:2–7

    Article  PubMed  CAS  Google Scholar 

  • Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ (1999) A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J Clin Endocrinol Metab 84:3642–3647

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Nieschlag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. M. Behre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Engelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Schwarzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Reproductive Medicine of the University, Domagkstr. 11, D-48129, Münster, Germany

    Eberhard Nieschlag

  2. Andrology Unit, Department of Urology of the University, Magdeburger Str. 16, D-06097, Halle, Germany

    Hermann M. Behre

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Nieschlag, E., Behre, H.M., Engelmann, U., Schwarzer, U. (2001). Male Contribution to Contraception. In: Nieschlag, E., Behre, H.M. (eds) Andrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04491-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-04491-9_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-04493-3

  • Online ISBN: 978-3-662-04491-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation